检验医学 ›› 2022, Vol. 37 ›› Issue (4): 392-395.DOI: 10.3969/j.issn.1673-8640.2022.04.018

• 综述与讲座·论著 • 上一篇    下一篇

斯氏放线棒菌研究现状

商希鹏, 李莎, 杜晶辉, 刘旭   

  1. 天津中医药大学第一附属医院 国家中医针灸临床医学研究中心检验科,天津 300380
  • 收稿日期:2020-04-27 修回日期:2020-09-10 出版日期:2022-04-30 发布日期:2022-06-07
  • 作者简介:商希鹏,男,1987年生,学士,主管技师,主要从事临床生化、免疫及微生物学研究。

Research status of Actinotignum schaalii

SHANG Xipeng, LI Sha, DU Jinghui, LIU Xu   

  1. Department of Clinical Laboratory,the First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine,National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion Tianjin 300380,China
  • Received:2020-04-27 Revised:2020-09-10 Online:2022-04-30 Published:2022-06-07

摘要:

斯氏放线棒菌为兼性厌氧革兰阳性杆菌,随着实验室培养条件的完善和基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)的广泛应用,检出率不断升高,其与泌尿系感染密切相关,对常用于治疗泌尿系感染的抗菌药物,如复方磺胺甲噁唑、喹诺酮类抗菌药物不敏感,对β-内酰胺类抗菌药物敏感。斯氏放线棒菌为新型尿路感染病原体,目前中国尚未见报道。为更好地了解斯氏放线棒菌,文章对斯氏放线棒菌的研究现状进行综述。

关键词: 斯氏放线棒菌, 泌尿系感染, 抗感染治疗

Abstract:

Actinotignum schaalii is facultative anaerobic Gram-positive Actinobacillus. With the improvement of clinical laboratory culture conditions and the wide usage of matrix-assisted laser desorption ionization time-of-flight mass spectrometry(MALDI-TOF MS),the detection rate of Actinotignum schaalii is increasing,and it is found that it is closely related to urinary tract infection. It is not sensitive to antibiotics commonly used,such as co-trimoxazole and quinolone,in the treatment of urinary tract infection,and it is sensitive to beta-lactamase. Actinotignum schaalii is a novel pathogen of urinary tract infection,and there has been no report on Actinotignum schaalii in China. In order to better understand Actinotignum schaalii,this review summarizes and expounds relevant reports abroad.

Key words: Actinotignum schaalii, Urinary tract infection, Anti-infection treatment

中图分类号: